☆ 4.8 Editorial Material

A New Era in the Treatment of Systemic Juvenile Idiopathic Arthritis

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Journal

NEW ENGLAND JOURNAL OF MEDICINE

Volume 367, Issue 25, Pages 2439-2440

Publisher

MASSACHUSETTS MEDICAL SOC

DOI: 10.1056/NEJMe1212640

Keywords

-

Categories

Medicine, General & Internal

Funding

NIAMS NIH HHS [R01 AR061297] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Review Rheumatology

Treatment of systemic juvenile idiopathic arthritis

Claas H. Hinze, Dirk Foell, Christoph Kessel

Summary: Systemic juvenile idiopathic arthritis (sJIA) is a disease characterized by severe systemic inflammation and arthritis. It poses challenges to rheumatologists treating pediatric and adult patients worldwide. Although treatment plans exist for classic sJIA, there is still a lack of clear treatment approaches for early sJIA without arthritis and complicated sJIA.

NATURE REVIEWS RHEUMATOLOGY (2023)

Add to Collection

Article Medicine, General & Internal

Surgical Treatment of Juvenile Idiopathic Arthritis in the Era of Novel Drug Therapies

Celine Klein, Vincent Barbier, Christophe Glorion, Richard Gouron

Summary: Juvenile idiopathic arthritis (JIA) is a common chronic rheumatic disease in children and significantly affects their daily life. The introduction of new drug treatments has reduced the need for surgery, but personalized surgical management is still required for patients who do not respond to drug therapy. This article provides an overview of the surgical indications and outcomes for various interventions in JIA, such as intra-articular corticosteroid injections, synovectomy, soft tissue release, surgery for growth disorders, and arthroplasty.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Biomarkers in Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Their Importance in COVID Era

Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher

Summary: Systemic juvenile idiopathic arthritis (sJIA) and its complication, macrophage activation syndrome (sJIA-MAS), are rare but serious diseases in childhood. Biomarkers are important for distinguishing these diseases and predicting treatment response and relapse risk.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Pediatrics

JAK inhibitors in systemic juvenile idiopathic arthritis

Tingyan He, Yu Xia, Ying Luo, Jun Yang

Summary: This study aimed to evaluate the efficacy and potential adverse effects of JAKi in patients with systemic juvenile idiopathic arthritis (SJIA). The results showed that JAKi may be an alternative or adjuvant agent for patients with persistently active disease, glucocorticoid-related adverse reactions, or SJIA-MAS.

FRONTIERS IN PEDIATRICS (2023)

Add to Collection

Article Cell Biology

Extracellular vesicles in systemic juvenile idiopathic arthritis

Justine Maller, Terry Morgan, Mayu Morita, Frank McCarthy, Yunshin Jung, Katrin J. Svensson, Joshua E. Elias, Claudia Macaubas, Elizabeth Mellins

Summary: The study suggests that intercellular communication mediated by extracellular vesicles plays an important role in the pathogenesis of systemic juvenile idiopathic arthritis. The number and cellular sources of extracellular vesicles differ between the active and inactive states of the disease and healthy controls.

JOURNAL OF LEUKOCYTE BIOLOGY (2023)

Add to Collection

Article Rheumatology

Variation in Treatment of Children Hospitalized With New-Onset Systemic Juvenile Idiopathic Arthritis in the US

Rosemary G. Peterson, Rui Xiao, Karen E. James, Hannah Katcoff, Brian T. Fisher, Pamela F. Weiss

Summary: The study found significant variation in the use of biologics and glucocorticoids in children hospitalized with new-onset systemic JIA, with noticeable differences between hospitals. Despite increasing evidence supporting the use of biologics for improved outcomes, many children did not receive biologic treatment and a high rate of glucocorticoid exposure persisted.

ARTHRITIS CARE & RESEARCH (2021)

Add to Collection

Review Immunology

Neutrophil Homeostasis and Emergency Granulopoiesis: The Example of Systemic Juvenile Idiopathic Arthritis

Bert Malengier-Devlies, Mieke Metzemaekers, Carine Wouters, Paul Proost, Patrick Matthys

Summary: Neutrophils play a crucial role in the innate immune system, using both oxidative and non-oxidative defense mechanisms to eradicate pathogens, and also act as decision shaping cells guiding other leukocytes for immune responses. The development and release of neutrophils are tightly regulated under both homeostatic and emergency conditions.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Rheumatology

A dysregulated interleukin-18-interferon-γ-CXCL9 axis impacts treatment response to canakinumab in systemic juvenile idiopathic arthritis

Tanja Hinze, Christoph Kessel, Claas H. Hinze, Julia Seibert, Hermann Gram, Dirk Foell

Summary: In patients with SJIA treated with canakinumab, baseline serum biomarkers such as IL-18 and IFN-gamma levels are associated with treatment outcome. Higher IL-18: CXCL9 and IFN-gamma: CXCL9 ratios at baseline are correlated with a better clinical response to canakinumab treatment. Further studies are needed to validate these findings and their applicability to patients with recent MAS.

RHEUMATOLOGY (2021)

Add to Collection

Article Rheumatology

Canakinumab in systemic juvenile idiopathic arthritis: real-world data from a retrospective Italian cohort

Arianna De Matteis, Claudia Bracaglia, Denise Pires Marafon, Anna Lucia Piscitelli, Maria Alessio, Roberta Naddei, Francesca Orlando, Giovanni Filocamo, Francesca Minoia, Angelo Ravelli, Jessica Tibaldi, Rolando Cimaz, Achille Marino, Gabriele Simonini, Maria Vincenza Mastrolia, Francesco La Torre, Ilaria Tricarico, Francesco Licciardi, Davide Montin, Maria Cristina Maggio, Clotilde Alizzi, Giorgia Martini, Adele Civino, Romina Gallizzi, Alma Nunzia Olivieri, Francesca Ardenti Morini, Giovanni Conti, Fabrizio De Benedetti, Manuela Pardeo

Summary: This study used real-world data to evaluate the effectiveness and safety of canakinumab in Italian patients with sJIA. The results showed that canakinumab was effective in treating sJIA and had no serious adverse events. The history of MAS and higher number of active joints were associated with poorer treatment outcomes.

RHEUMATOLOGY (2022)

Add to Collection

Review Medicine, General & Internal

Lung Involvement in Systemic Juvenile Idiopathic Arthritis: A Narrative Review

Duilio Petrongari, Paola Di Filippo, Francesco Misticoni, Giulia Basile, Sabrina Di Pillo, Francesco Chiarelli, Marina Attanasi

Summary: Systemic juvenile idiopathic arthritis associated with lung disorders (sJIA-LD) is a subtype of sJIA characterized by chronic life-threatening pulmonary disorders. It was exceptionally rare before 2013, but the reported prevalence is now approximately 6.8%. Clinically, children with sJIA-LD exhibit relatively mild symptoms, but the severity of pulmonary inflammation is high. sJIA-LD is often associated with early onset, macrophage activation syndrome, and high interleukin-18 circulating levels.

DIAGNOSTICS (2022)

Add to Collection

Review Medicine, General & Internal

Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives

William G. Ambler, Kabita Nanda, Karen Brandt Onel, Susan Shenoi

Summary: This review focuses on the treatment options and potential future therapeutics for systemic juvenile idiopathic arthritis (SJIA). Recent advancements in targeted therapies have improved patient outcomes, but there are still subsets of patients with refractory disease and severe complications.

ANNALS OF MEDICINE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

The Role of Serum Calprotectin in Defining Disease Outcomes in Non-Systemic Juvenile Idiopathic Arthritis: A Pilot Study

Debora Mariarita d'Angelo, Marina Attanasi, Giulia Di Donato, Giuseppe Lapergola, Mariarosaria Flacco, Francesco Chiarelli, Emma Altobelli, Luciana Breda

Summary: The study investigates the potential role of serum calprotectin as a biomarker for disease activity and flare/remission in patients with juvenile idiopathic arthritis (JIA). The results suggest that serum calprotectin has a dual role in predicting future relapse and treatment response, which is important for therapeutic decisions and management during follow-up.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Medicine, General & Internal

Ankle Magnetic Resonance Imaging in Juvenile Idiopathic Arthritis Versus Non-Juvenile Idiopathic Arthritis Patients with Arthralgia

Monika Ostrowska, Emil Michalski, Piotr Gietka, Malgorzata Manczak, Magdalena Posadzy, Iwona Sudol-Szopinska

Summary: This study compared MRI findings between patients clinically suspected of Juvenile Idiopathic Arthritis (JIA) and patients with ankle arthralgia of unknown cause. The results showed that inflammatory features were observed on MRI, with tenosynovitis being significantly more common in JIA patients. However, the MRI summarized score did not effectively differentiate between JIA and non-JIA patients.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Pediatrics

Kawasaki Disease and Systemic Juvenile Idiopathic Arthritis - Two Ends of the Same Spectrum

Ellen Go, Mira van Veenendaal, Cedric Manlhiot, Rayfel Schneider, Brian W. McCrindle, Rae S. M. Yeung

Summary: This study describes the disease course of a small proportion of patients with both Kawasaki disease and systemic juvenile idiopathic arthritis, characterized by refractory Kawasaki disease, high prevalence of coronary artery dilatation, and shared immunopathology potentially linking the two conditions.

FRONTIERS IN PEDIATRICS (2021)

Add to Collection

Article Rheumatology

Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease

Piero Ruscitti, Valentina Natoli, Alessandro Consolaro, Roberta Caorsi, Silvia Rosina, Gabriella Giancane, Roberta Naddei, Ilenia Di Cola, Claudia Di Muzio, Onorina Berardicurti, Daniela Iacono, Ilenia Pantano, Gelsomina Rozza, Silvia Rossi, Ludovico De Stefano, Silvia Balduzzi, Antonio Vitale, Francesco Caso, Luisa Costa, Marcella Prete, Luca Navarini, Annamaria Iagnocco, Fabiola Atzeni, Giuliana Guggino, Federico Perosa, Luca Cantarini, Bruno Frediani, Carlomaurizio Montecucco, Francesco Ciccia, Paola Cipriani, Marco Gattorno, Roberto Giacomelli, Angelo Ravelli

Summary: This study compares the clinical features and treatments of systemic JIA and adult-onset Still's disease. The results reveal remarkable disparities in the prevalence of clinical manifestations between the two illnesses, which may partly depend on their classification by different criteria.

RHEUMATOLOGY (2022)

Add to Collection

Letter Rheumatology

Response to: 'Successful treatment of plasma exchange for refractory systemic juvenile idiopathic arthritis complicated with macrophage activation syndrome and severe lung disease' by Sato et al

Vivian E. Saper, Guangbo Chen, R. Paul Guillerman, Purvesh Khatri, Randy Q. Cron, Elizabeth D. Mellins

ANNALS OF THE RHEUMATIC DISEASES (2022)

Add to Collection

Article Rheumatology

Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles

Vivian E. Saper, Michael J. Ombrello, Adriana H. Tremoulet, Gonzalo Montero-Martin, Sampath Prahalad, Scott Canna, Chisato Shimizu, Gail Deutsch, Serena Y. Tan, Elaine F. Remmers, Dimitri Monos, Timothy Hahn, Omkar K. Phadke, Elaine Cassidy, Ian Ferguson, Vamsee Mallajosyula, Jianpeng Xu, Jaime S. Rosa Duque, Gilbert T. Chua, Debopam Ghosh, Ann Marie Szymanski, Danielle Rubin, Jane C. Burns, Lu Tian, Marcelo A. Fernandez-Vina, Elizabeth D. Mellins, Jill A. Hollenbach

Summary: Drug reaction with eosinophilia and systemic symptoms (DRESS) can occur in Still's disease patients treated with IL-1/IL-6 inhibitors, with features such as eosinophilia, liver enzyme elevation, and persistent rash. HLA-DRB1*15 haplotypes are significantly enriched in Still's disease with DRESS. Pre-prescription HLA typing and vigilance for serious reactions to these drugs are recommended.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Add to Collection

Article Biochemical Research Methods

Tuning DO:DM Ratios Modulates MHC Class II Immunopeptidomes

Niclas Olsson, Wei Jiang, Lital N. Adler, Elizabeth D. Mellins, Joshua E. Elias

Summary: This study investigates the effects of DO:DM ratios on peptide presentation by creating a panel of HLA-DR4-expressing APC lines and analyzing over 10,000 unique DR4-presented peptides. The findings provide insights into the characteristics that influence peptide presentation and have implications for HLA-II prediction algorithms and research strategies.

MOLECULAR & CELLULAR PROTEOMICS (2022)

Add to Collection

Article Cell Biology

Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity

Saborni Chakraborty, Joseph C. Gonzalez, Benjamin L. Sievers, Vamsee Mallajosyula, Srijoni Chakraborty, Megha Dubey, Usama Ashraf, Bowie Yik-Ling Cheng, Nimish Kathale, Kim Quyen Thi Tran, Courtney Scallan, Aanika Sinnott, Arianna Cassidy, Steven T. Chen, Terri Gelbart, Fei Gao, Yarden Golan, Xuhuai Ji, Seunghee Kim-Schulze, Mary Prahl, Stephanie L. Gaw, Sacha Gnjatic, Thomas U. Marron, Miriam Merad, Prabhu S. Arunachalam, Scott D. Boyd, Mark M. Davis, Marisa Holubar, Chaitan Khosla, Holden T. Maecker, Yvonne Maldonado, Elizabeth D. Mellins, Kari C. Nadeau, Bali Pulendran, Upinder Singh, Aruna Subramanian, Paul J. Utz, Robert Sherwood, Sheng Zhang, Prasanna Jagannathan, Gene S. Tan, Taia T. Wang

Summary: A damaging inflammatory response in severe COVID-19 is associated with early non-neutralizing, afucosylated IgG antibodies specific to SARS-CoV-2. Human IgG-Fc-gamma receptor interactions regulate inflammation in the lung, and antibodies elicited by mRNA SARS-CoV-2 vaccines have reduced inflammatory potential.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Add to Collection

Article Cell Biology

Regulation of the BCR signalosome by the class II peptide editor, H2-M, affects the development and repertoire of innate-like B cells

Debopam Ghosh, Tho D. Pham, Padma P. Nanaware, Deepanwita Sengupta, Lital N. Adler, Caiyun G. Li, Xiao He, Mary E. O'Mara, Aaron B. Kantor, Khoa D. Nguyen, Yang Yang, Laurence C. Eisenlohr, Peter E. Jensen, Leonore A. Herzenberg, Lawrence J. Stern, Scott D. Boyd, Eliver E. B. Ghosn, Elizabeth D. Mellins

Summary: The absence of H2-M protein affects the survival and immunoglobulin selection of B-1 cells, and also alters the specificity of the B-1 cell clonal repertoire.

CELL REPORTS (2022)

Add to Collection

Article Allergy

Proinflammatory polarization of monocytes by particulate air pollutants is mediated by induction of trained immunity in pediatric asthma

Hesam Movassagh, Mary Prunicki, Abhinav Kaushik, Xiaoying Zhou, Diane Dunham, Eric M. M. Smith, Ziyuan He, German R. Aleman R. Muench, Minyi Shi, Annika K. K. Weimer, Shu Cao, Sandra Andorf, Amir Feizi, Michael P. P. Snyder, Pejman Soroosh, Elizabeth D. D. Mellins, Kari C. C. Nadeau

Summary: This study found that exposure to fine particulate matter (PM2.5) leads to specific alterations in monocytes, especially in children with asthma. Further mechanistic research revealed that fine particulate matter induces innate trained immunity in circulating monocytes, resulting in an enhanced inflammatory response. These findings suggest that the alterations of monocytes may serve as an immune signature for pediatric asthma, and pollution-induced trained immunity could be a potential therapeutic target for asthmatic children.

ALLERGY (2023)

Add to Collection

Article Developmental Biology

Evaluation of C4 gene copy number in Pediatric Acute Neuropsychiatric Syndrome

Agnieszka Kalinowski, Lu Tian, Reenal Pattni, Hanna Ollila, Maroof Khan, Cindy Manko, Melissa Silverman, Meiqian Ma, Laurie Columbo, Bahare Farhadian, Susan Swedo, Tanya Murphy, Mats Johnson, Elisabeth Fernell, Christopher Gillberg, Margo Thienemann, Elizabeth D. Mellins, Douglas F. Levinson, Alexander E. Urban, Jennifer Frankovich

Summary: Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) is a sudden-onset neuropsychiatric disorder with an increased prevalence of co-morbid autoimmune illness, particularly arthritis. PANS patients with low C4B copy number are at higher risk for subsequent Juvenile Idiopathic Arthritis (JIA) diagnosis. There is a possible association between low C4B and PANS age of onset, suggesting a potential role of C4B in different types of arthritis.

DEVELOPMENTAL NEUROSCIENCE (2023)

Add to Collection

Article Developmental Biology

Post-infectious inflammation, autoimmunity, and OCD: Sydenham Chorea, Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal infection (PANDAS), and Pediatric Acute-onset Neuropsychiatric Disorder (PANS)

Allison Vreeland, Denise Calaprice, Noga Or-Geva, Richard E. Frye, Dritan Agalliu, Herbert M. Lachman, Christopher Pittenger, Stefano Pallanti, Kyle Williams, Meiqian Ma, Margo Thienemann, Antonella Gagliano, Elizabeth Mellins, Jennifer Frankovich

Summary: Post-infectious neuroinflammation is implicated in acute onset obsessive-compulsive disorder. This review article outlines the evidence supporting the role of neuroinflammation in these disorders, including animal models, imaging studies, and research on sleep and metabolites. The authors encourage interdisciplinary collaboration to further research on clinical syndromes with neuropsychiatric manifestations.

DEVELOPMENTAL NEUROSCIENCE (2023)

Add to Collection

Article Rheumatology

Tmem178 Negatively Regulates IL-1β Production Through Inhibition of the NLRP3 Inflammasome

Kunjan Khanna, Hui Yan, Muneshwar Mehra, Nidhi Rohatgi, Gabriel Mbalaviele, Elizabeth D. Mellins, Roberta Faccio

Summary: This study reveals the regulatory mechanism of NLRP3 inflammasome in systemic juvenile idiopathic arthritis (sJIA). The down-regulation of TMEM178 levels is associated with disease activity and may serve as a marker for identifying patients who would benefit from inflammasome targeting.

ARTHRITIS & RHEUMATOLOGY (2023)

Add to Collection

Article Engineering, Biomedical

Shortwave-infrared-light-emitting probes for the in vivo tracking of cancer vaccines and the elicited immune responses

Fuqiang Ren, Feifei Wang, Ani Baghdasaryan, Ying Li, Haoran Liu, Rusiou Hsu, Chuchu Wang, Jiachen Li, Yeteng Zhong, Felix Salazar, Chun Xu, Yingying Jiang, Zhuoran Ma, Guanzhou Zhu, Xiang Zhao, Kerry Kaili Wong, Richard Willis, K. Christopher Garcia, Anna Wu, Elizabeth Mellins, Hongjie Dai

Summary: This study reports a cancer vaccine that can track and image immune cells non-invasively in vivo, providing insights into the immune responses induced by vaccination. The vaccine rapidly migrates to lymph nodes through lymphatic vessels and eradicates pre-existing tumors with two doses. The use of nanoparticle-based vaccines and imaging probes emitting infrared light has important implications for the design and optimization of immunotherapies.

NATURE BIOMEDICAL ENGINEERING (2023)

Add to Collection

Editorial Material Health Care Sciences & Services

Synchrony 2022: The Role of Neuroinflammation in Behavioral Exacerbations in Autism Spectrum Disorder

Jennifer Frankovich, Heer Nanda, Elizabeth D. D. Mellins, Harumi Jyonouchi, Richard G. G. Boles, Stephen J. J. Walker, John Gaitanis, Richard E. E. Frye

JOURNAL OF PERSONALIZED MEDICINE (2023)

Add to Collection

Article Cell Biology

Extracellular vesicles in systemic juvenile idiopathic arthritis

Justine Maller, Terry Morgan, Mayu Morita, Frank McCarthy, Yunshin Jung, Katrin J. Svensson, Joshua E. Elias, Claudia Macaubas, Elizabeth Mellins

Summary: The study suggests that intercellular communication mediated by extracellular vesicles plays an important role in the pathogenesis of systemic juvenile idiopathic arthritis. The number and cellular sources of extracellular vesicles differ between the active and inactive states of the disease and healthy controls.

JOURNAL OF LEUKOCYTE BIOLOGY (2023)

Add to Collection

Meeting Abstract Rheumatology

Large-Scale Targeted Sequencing Study Links Systemic Juvenile Idiopathic Arthritis with Rare Variants of MEFV, LYST, STXBP2, UNC13D

Mariana Correia Marques, Danielle Rubin, Emily Shuldiner, Elizabeth Schmitz, Elizabeth Baskin, Andrew Patt, Alexei Grom, Dirk Foell, Marco Gattorno, John Bohnsack, Rae Yeung, Sampath Prahalad, Elizabeth Mellins, Jordi Anton, Dirk Foell, Marco Gattorno, John Bohnsack, Rae Yeung, Sampath Prahalad, Elizabeth Mellins, Jordi Anton, Claudio Len, Sheila Oliveira, Patricia Woo, Seza Ozen, Michael Ombrello

ARTHRITIS & RHEUMATOLOGY (2022)

Add to Collection

Meeting Abstract Rheumatology

Regulatory Haplotype of CXCR4 Is Associated with sJIA and Corelates with Enhanced Neutrophil and CD14+Monocyte Migration

Hiroto Nakano, Emily Shuldiner, Anne Hinks, Marc Sudman, Elaine Remmers, Colleen Satorius, Elizabeth Schmitz, Victoria Arthur, Patricia Woo, Alexei Grom, Dirk Foell, John Bohnsack, Marco Gattorno, Seza Ozen, Sampath Prahalad, Rae Yeung, Elizabeth Mellins, Sheila Oliveira, Jordi Anton, Claudio Len, Carol Lake, Ly-Lan Bergeron, Michelle Millwood, Estefania de los Santos, Mariana Correia Marques, Carl Langefeld, Susan Thompson, Wendy Thomson, Michael Ombrello

ARTHRITIS & RHEUMATOLOGY (2022)

Add to Collection

Meeting Abstract Immunology

Two distinct brain-homing monocyte subsets identified in pediatric acute-onset neuropsychiatric syndrome (PANS) are immunosuppressive and neuroprotective

Shamma Rahman, Achia Khatun, Fabian Gaertner, Claudia Macaubas, Nytzia Licona, Laurie Columbo, Bahare Farhadian, Theresa Willett, Margo Thienemann, Jennifer Frankovich, Elizabeth Mellins

JOURNAL OF CLINICAL IMMUNOLOGY (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.